A Phase I/II Safety Study of DE-120 Injectable Solution for Age-related Macular Degeneration
Clinical trial NCT02022501 · COMPLETED
Trial details
- NCT number
- NCT02022501
- Sponsor
- Santen Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2016-04-21
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.